Company: NIVFW
Filing Date: 2025-08-22
Form Type: DRS
Source: 0001213900-25-079717
Chunk: 109

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-22
Form: DRS
Chunk 109
---
 dividends on our ordinary shares would be
at the discretion of our Board of Directors, subject to applicable laws, and would depend on our financial condition, results of operations,
capital requirements, general business conditions, and other factors that our Board of Directors may deem relevant.

<div align='center'>60

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</div>

The following discussion and analysis of our results of operations and financial condition should be read together with our consolidated financial statements and the notes thereto and other financial information, which are included elsewhere in this prospectus. Our financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). In addition, our financial statements and the financial information included in this prospectus reflect our organizational transactions and have been prepared as if our current corporate structure had been in place throughout the relevant periods.

This section contains forward-looking statements. These forward-looking statements are subject to various factors, risks and uncertainties that could cause actual results to differ materially from those reflected in these forward-looking statements. Further, as a result of these factors, risks and uncertainties, the forward-looking events may not occur. Relevant factors, risks and uncertainties include, but are not limited to, those discussed in the section entitled “Business,” “Risk Factors” and elsewhere in this prospectus. Readers are cautioned not to place undue reliance on forward-looking statements, which reflect management’s beliefs and opinions as of the date of this prospectus. We are not obligated to publicly update or revise any forward -looking statements, whether as a result of new information, future events or otherwise. See “Cautionary Note Regarding Forward-Looking Statements.”

Overview

NewGenIvf is an assisted reproductive
services (“ARS”) provider in Asia Pacific. Since the establishment of its first clinic in Thailand in 2014, it has established
itself as a long-standing ARS provider in the region. NewGenIvf’s mission is to assist couples and individuals across Asia Pacific,
regardless of fertility challenges that they may face, to fulfil their dreams of building families and to increase their access to fertility
treatments. Its strategic presence in Thailand, Cambodia, and Kyrgyzstan positions the company to take advantage of opportunities across
Asia Pacific.

NewGenIvf is still in the
early stage of materializing its long-term objective of building a comprehensive, sophisticated and high-end ARS platform for its clients
and providing personalized solutions based on NewGenIvf’s